President-elect Donald Trump announced last Thursday, Nov. 14, that Kennedy, 70, was his pick to head the Department of ...

After a three-year negotiation, the FDA has dropped its objection to allowing patients to self-titrate dosing of smoked ...

Managed Healthcare Executive provides C-suite executives at health plans and provider organizations with news, analysis, ...

The FDA has approved UCB's Bimzelx for moderate-to-severe hidradenitis suppurativa, offering a new treatment option for this ...

A total of 17 lots are now part of the recall of Clonazepam because some cartons have the wrong strength on the label.

Managed Healthcare Executive provides C-suite executives at health plans and provider organizations with news, analysis, ...

Medicare fraud costs Americans about $60 billion each year and healthcare plans are stepping in spread awareness and stop ...

In contrast to electroconvulsive therapy, patients are not sedated during the treatments. Studies of a protocol called ...

A 25-year-old woman with vitiligo universalis, a severe form of vitiligo that causes nearly complete loss of skin color ...

Efforts have been made in recent years to clarify the value of exercise as an adjunctive or independent treatment for major ...

After feedback from the FDA, the companies have voluntarily withdrawn the previous biologics licensing application for ...

The FDA has provided a date of April 18, 2025, to review the application for Dupixent to treat patients with chronic ...